6-(3-Methyl-1,2,4-oxadiazol-5-yl)-N-{4-[(piperazin-1-yl)methyl]pyridin-2-yl}-1H-benzimidazol-2-amine

ID: ALA4575832

PubChem CID: 129245476

Max Phase: Preclinical

Molecular Formula: C20H22N8O

Molecular Weight: 390.45

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1noc(-c2ccc3nc(Nc4cc(CN5CCNCC5)ccn4)[nH]c3c2)n1

Standard InChI:  InChI=1S/C20H22N8O/c1-13-23-19(29-27-13)15-2-3-16-17(11-15)25-20(24-16)26-18-10-14(4-5-22-18)12-28-8-6-21-7-9-28/h2-5,10-11,21H,6-9,12H2,1H3,(H2,22,24,25,26)

Standard InChI Key:  FQLDODIEEKFQOP-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 29 33  0  0  0  0  0  0  0  0999 V2000
   21.5097  -17.4953    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.5086  -18.3189    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.2207  -18.7320    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.9345  -18.3185    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.9317  -17.4917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.2189  -17.0864    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.7978  -17.0869    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.0860  -17.4956    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.3358  -17.1591    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.0013  -18.3081    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.1980  -18.4783    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.7898  -17.7668    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.9709  -17.7675    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.5591  -18.4790    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.9764  -19.1912    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.7939  -19.1870    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.6420  -17.0804    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.3512  -17.4864    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   24.3517  -18.3094    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.0610  -18.7194    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.7737  -18.3075    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   25.7726  -17.4852    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.0588  -17.0748    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.5693  -19.9087    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.7529  -19.9981    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.5868  -20.8023    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3007  -21.2116    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.9093  -20.6577    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.8378  -21.1425    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  1  7  1  0
  7  8  1  0
  8  9  2  0
  9 12  1  0
 11 10  1  0
 10  8  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 11  1  0
  5 17  1  0
 17 18  1  0
 18 19  1  0
 18 23  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 24  1  0
 15 24  1  0
 26 29  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4575832

    ---

Associated Targets(Human)

TBK1 Tchem Serine/threonine-protein kinase TBK1 (3746 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
IKBKE Tchem Inhibitor of nuclear factor kappa B kinase epsilon subunit (3311 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
IKBKE Tchem IKK epsilon/TBK1 (53 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SK-MEL-2 (46422 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ACHN (49357 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 390.45Molecular Weight (Monoisotopic): 390.1917AlogP: 2.47#Rotatable Bonds: 5
Polar Surface Area: 107.79Molecular Species: BASEHBA: 8HBD: 3
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 11.14CX Basic pKa: 9.21CX LogP: 2.32CX LogD: 0.60
Aromatic Rings: 4Heavy Atoms: 29QED Weighted: 0.48Np Likeness Score: -1.64

References

1. Lefranc J, Schulze VK, Hillig RC, Briem H, Prinz F, Mengel A, Heinrich T, Balint J, Rengachari S, Irlbacher H, Stöckigt D, Bömer U, Bader B, Gradl SN, Nising CF, von Nussbaum F, Mumberg D, Panne D, Wengner AM..  (2020)  Discovery of BAY-985, a Highly Selective TBK1/IKKε Inhibitor.,  63  (2): [PMID:31859507] [10.1021/acs.jmedchem.9b01460]

Source